Your browser doesn't support javascript.
loading
Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy.
Puig-Saus, Cristina; Sennino, Barbara; Peng, Songming; Wang, Clifford L; Pan, Zheng; Yuen, Benjamin; Purandare, Bhamini; An, Duo; Quach, Boi B; Nguyen, Diana; Xia, Huiming; Jilani, Sameeha; Shao, Kevin; McHugh, Claire; Greer, John; Peabody, Phillip; Nayak, Saparya; Hoover, Jonathan; Said, Sara; Jacoby, Kyle; Dalmas, Olivier; Foy, Susan P; Conroy, Andrew; Yi, Michael C; Shieh, Christine; Lu, William; Heeringa, Katharine; Ma, Yan; Chizari, Shahab; Pilling, Melissa J; Ting, Marc; Tunuguntla, Ramya; Sandoval, Salemiz; Moot, Robert; Hunter, Theresa; Zhao, Sidi; Saco, Justin D; Perez-Garcilazo, Ivan; Medina, Egmidio; Vega-Crespo, Agustin; Baselga-Carretero, Ignacio; Abril-Rodriguez, Gabriel; Cherry, Grace; Wong, Deborah J; Hundal, Jasreet; Chmielowski, Bartosz; Speiser, Daniel E; Bethune, Michael T; Bao, Xiaoyan R; Gros, Alena.
Affiliation
  • Puig-Saus C; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA. cpuigsaus@mednet.ucla.edu.
  • Sennino B; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA, USA. cpuigsaus@mednet.ucla.edu.
  • Peng S; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. cpuigsaus@mednet.ucla.edu.
  • Wang CL; Broad Stem Cell Research Center, UCLA, Los Angeles, CA, USA. cpuigsaus@mednet.ucla.edu.
  • Pan Z; PACT Pharma, San Francisco, CA, USA.
  • Yuen B; PACT Pharma, San Francisco, CA, USA.
  • Purandare B; PACT Pharma, San Francisco, CA, USA.
  • An D; PACT Pharma, San Francisco, CA, USA.
  • Quach BB; PACT Pharma, San Francisco, CA, USA.
  • Nguyen D; PACT Pharma, San Francisco, CA, USA.
  • Xia H; PACT Pharma, San Francisco, CA, USA.
  • Jilani S; PACT Pharma, San Francisco, CA, USA.
  • Shao K; PACT Pharma, San Francisco, CA, USA.
  • McHugh C; McDonnell Genome Institute, Washington University School of Medicine, St Louis, MO, USA.
  • Greer J; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Peabody P; PACT Pharma, San Francisco, CA, USA.
  • Nayak S; PACT Pharma, San Francisco, CA, USA.
  • Hoover J; PACT Pharma, San Francisco, CA, USA.
  • Said S; PACT Pharma, San Francisco, CA, USA.
  • Jacoby K; PACT Pharma, San Francisco, CA, USA.
  • Dalmas O; PACT Pharma, San Francisco, CA, USA.
  • Foy SP; PACT Pharma, San Francisco, CA, USA.
  • Conroy A; PACT Pharma, San Francisco, CA, USA.
  • Yi MC; PACT Pharma, San Francisco, CA, USA.
  • Shieh C; PACT Pharma, San Francisco, CA, USA.
  • Lu W; PACT Pharma, San Francisco, CA, USA.
  • Heeringa K; PACT Pharma, San Francisco, CA, USA.
  • Ma Y; PACT Pharma, San Francisco, CA, USA.
  • Chizari S; PACT Pharma, San Francisco, CA, USA.
  • Pilling MJ; PACT Pharma, San Francisco, CA, USA.
  • Ting M; PACT Pharma, San Francisco, CA, USA.
  • Tunuguntla R; PACT Pharma, San Francisco, CA, USA.
  • Sandoval S; PACT Pharma, San Francisco, CA, USA.
  • Moot R; PACT Pharma, San Francisco, CA, USA.
  • Hunter T; PACT Pharma, San Francisco, CA, USA.
  • Zhao S; PACT Pharma, San Francisco, CA, USA.
  • Saco JD; PACT Pharma, San Francisco, CA, USA.
  • Perez-Garcilazo I; PACT Pharma, San Francisco, CA, USA.
  • Medina E; McDonnell Genome Institute, Washington University School of Medicine, St Louis, MO, USA.
  • Vega-Crespo A; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Baselga-Carretero I; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Abril-Rodriguez G; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Cherry G; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Wong DJ; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Hundal J; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Chmielowski B; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.
  • Speiser DE; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Bethune MT; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Bao XR; McDonnell Genome Institute, Washington University School of Medicine, St Louis, MO, USA.
  • Gros A; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Nature ; 615(7953): 697-704, 2023 03.
Article in En | MEDLINE | ID: mdl-36890230
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: CD8-Positive T-Lymphocytes / Immune Checkpoint Inhibitors / Immunotherapy / Melanoma / Antigens, Neoplasm Limits: Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: CD8-Positive T-Lymphocytes / Immune Checkpoint Inhibitors / Immunotherapy / Melanoma / Antigens, Neoplasm Limits: Humans Language: En Year: 2023 Type: Article